DK0635495T3 - Benzospiroalkenderivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende dem - Google Patents

Benzospiroalkenderivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende dem

Info

Publication number
DK0635495T3
DK0635495T3 DK94401547T DK94401547T DK0635495T3 DK 0635495 T3 DK0635495 T3 DK 0635495T3 DK 94401547 T DK94401547 T DK 94401547T DK 94401547 T DK94401547 T DK 94401547T DK 0635495 T3 DK0635495 T3 DK 0635495T3
Authority
DK
Denmark
Prior art keywords
branched
linear
group
unsubstituted
substituted
Prior art date
Application number
DK94401547T
Other languages
Danish (da)
English (en)
Inventor
Alex Cordi
Jean-Michel Lacoste
Michel Laubie
Tony Verbeuren
Jean-Jacques Descombes
Mark Millan
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Application granted granted Critical
Publication of DK0635495T3 publication Critical patent/DK0635495T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Vascular Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
DK94401547T 1993-07-20 1994-07-06 Benzospiroalkenderivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende dem DK0635495T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9308859A FR2707981B1 (fr) 1993-07-20 1993-07-20 Nouveaux dérivés de benzospiroalcène, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.

Publications (1)

Publication Number Publication Date
DK0635495T3 true DK0635495T3 (da) 1999-06-14

Family

ID=9449385

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94401547T DK0635495T3 (da) 1993-07-20 1994-07-06 Benzospiroalkenderivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende dem

Country Status (12)

Country Link
US (2) US5486532A (ja)
EP (1) EP0635495B1 (ja)
JP (1) JP3103271B2 (ja)
AT (1) ATE171166T1 (ja)
AU (1) AU673438B2 (ja)
CA (1) CA2128119C (ja)
DE (1) DE69413333T2 (ja)
DK (1) DK0635495T3 (ja)
ES (1) ES2124379T3 (ja)
FR (1) FR2707981B1 (ja)
NZ (1) NZ264037A (ja)
ZA (1) ZA945336B (ja)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04174725A (ja) * 1990-10-30 1992-06-22 Kanebo Ltd 紡績装置におけるドラフト装置
FR2787450B1 (fr) * 1998-12-18 2001-01-26 Adir Nouveaux derives spiroimidazoliniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
EP2323734A1 (en) * 2008-08-04 2011-05-25 Schering Corporation Cyclopropylchromene derivatives as modulators of the alpha-2c receptor
TW201026691A (en) 2008-10-07 2010-07-16 Schering Corp Biaryl spiroaminooxazoline analogues as alpha2C adrenergic receptor modulators
TW201026672A (en) * 2008-10-07 2010-07-16 Schering Corp Spiroaminooxazoline analogues as alpha2C adrenergic receptor modulators
US20130079271A1 (en) * 2009-10-01 2013-03-28 Kevin D. McCormick Reversed biaryl spiroaminooxazoline analogues as alpha2c adrenergic receptor modulators
CN110393714B (zh) * 2019-08-02 2022-09-02 上海市肿瘤研究所 一种抗肿瘤药物、合成方法及应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3429892A (en) * 1967-03-14 1969-02-25 Smithkline Corp Spiro(naphthalene-2,2'-oxazolidine) compounds
US4200642A (en) * 1978-08-21 1980-04-29 Pfizer Inc. Spiro-oxazolidindiones
US4226875A (en) * 1979-04-02 1980-10-07 Pfizer Inc. Novel spiro-oxazolidinediones
ZA832679B (en) * 1982-05-07 1983-12-28 Ici Plc Indoline derivatives
FR2709306B1 (fr) * 1993-07-20 1995-10-20 Adir Nouveaux dérivés de benzospiroalcène, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
FR2707982B1 (fr) * 1993-07-20 1995-09-01 Adir Nouveaux dérivés de benzospiroalcène, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.

Also Published As

Publication number Publication date
US5486532A (en) 1996-01-23
EP0635495A3 (fr) 1995-02-22
ZA945336B (en) 1995-02-28
ES2124379T3 (es) 1999-02-01
AU673438B2 (en) 1996-11-07
DE69413333T2 (de) 1999-05-12
DE69413333D1 (de) 1998-10-22
FR2707981B1 (fr) 1995-09-01
FR2707981A1 (fr) 1995-01-27
EP0635495B1 (fr) 1998-09-16
ATE171166T1 (de) 1998-10-15
JPH07165728A (ja) 1995-06-27
US5648374A (en) 1997-07-15
JP3103271B2 (ja) 2000-10-30
AU6754894A (en) 1995-02-02
CA2128119C (fr) 2002-02-26
NZ264037A (en) 1995-04-27
CA2128119A1 (fr) 1995-01-21
EP0635495A2 (fr) 1995-01-25

Similar Documents

Publication Publication Date Title
ES2109672T3 (es) 1,4-tiazepinas condensadas hipolipidemicas.
DK0457686T3 (da) Hidtil ukendte aminopiperidin-, aminopyrrolidin- og aminoperhydroazepinderivater, fremgangsmåder til fremstilling heraf og farmaceutiske midler, som indeholder dem
DK0635497T3 (da) Benzospiroalkenderivater, fremgangsmåder til deres fremstilling og farmaceutiske sammensætninger, der indeholder disse
DK0635495T3 (da) Benzospiroalkenderivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende dem
DK0452204T3 (da) Hidtil ukendte 3-aminochromanderivater, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem
DK0635496T3 (da) Benzospiroalkenderivater, fremgangsmåde til deres fremstilling og farmaceutiske sammensætninger indeholdende sådanne
MY109729A (en) Benzofuranylimidazole derivatives, a process for the preparation and therapeutical compositions containing the same
DK0412015T3 (da) Hidtil ukendte N-(23-vincristinoyl)- og N-(5-noranhydro-23-vinblastinoyl)-1-aminomethylphosphon- syrederivater, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem
AU659738B2 (en) New pyrrolothienopyrazine compounds, processes for the preparation thereof, and pharmaceutical compositions containing them
AU5251093A (en) New p-(bis(2-chloroethyl)amino)phenylalanine compounds, process for preparing them and pharmaceutical compositions containing them
DK0518753T3 (da) Hidtil ukendte 1,5-diyn-3-cykloalkenderivater, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem
PL304334A1 (en) Pharmaceutical composition of gastric protective action, including antiulceric one and method of treating diseases of gastrointestinal tract